ARTICLE | Financial News
ApcinteX completes venture financing
February 3, 2017 5:34 PM UTC
Hemophilia play ApcinteX Ltd. (Cambridge, U.K.) raised £14 million ($17.5 million) in a series A round co-led by Touchstone Innovations and Medicxi on Feb. 2....
BCIQ Company Profiles